Spreading the News: IPCF funded study creating buzz in the medical community!
Recently, IPCF funded a study that has made some great breakthroughs in prostate cancer research. In this study, a group of researchers have completed a proof-of-principle study, with results indicating potential for a urine test for prostate cancer. In this research, scientists aimed to identify sensitive and specific diagnostic biomarkers for prostate cancer in urine samples.
These findings are getting noticed in the medical community.
Senior study author and IPCF board member, Ranjan Perera explained: “A simple and noninvasive urine test for prostate cancer would be a significant step forward in diagnosis. Tissue biopsies are invasive and notoriously difficult because they often miss cancer cells, and existing tests, such as prostate-specific antigen elevation, are not very helpful in identifying cancer.”
The investigators emphasize that this is a proof-of-principle study for the urine test, and it must be validated in additional, larger studies before it is ready for clinical use.